|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7048 | |
| A61K 31/365 | |||
| A61P 17/00 | |||
| A61P 37/08 | |||
| A61K 9/00 | |||
| A61K 47/10 | |||
| A61K 9/06 |
| (11) | Number of the document | 3074021 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14809609.2 |
| Date of filing the European patent application | 2014-11-28 | |
| (97) | Date of publication of the European application | 2016-10-05 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/075927 |
| Date | 2014-11-28 |
| (87) | Number | WO 2015/079016 |
| Date | 2015-06-04 |
| (30) | Number | Date | Country code |
| 13306633 | 2013-11-29 | EP |
| (72) |
HACINI-RACHINEL, Feriel, FR
VIAL, Emmanuel, FR
JOMARD, André, FR
|
| (73) |
Galderma SA,
Zugerstrasse 8, 6330 Cham,
CH
|
| (54) | COMPOUND OF THE AVERMECTIN FAMILY OR OF THE MILBEMYCIN FAMILY FOR THE TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS |
| COMPOUND OF THE AVERMECTIN FAMILY OR OF THE MILBEMYCIN FAMILY FOR THE TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS |